Charles Schwab’s CytRx Corp CYTR Stock Holding History

Charles Schwab’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-21,000	Closed	-$56K	–	3224
2017 Q1	$56K	Hold	21,000	–	–	﹤0.01%	3038
2016 Q4	$47K	Hold	21,000	–	–	﹤0.01%	3067
2016 Q3	$75K	Hold	21,000	–	–	﹤0.01%	3021
2016 Q2	$281K	Hold	21,000	–	–	﹤0.01%	2810
2016 Q1	$338K	Buy	21,000 +7,367	+54%	+$101K	﹤0.01%	2729
2015 Q4	$217K	Hold	13,633	–	–	﹤0.01%	2950
2015 Q3	$194K	Hold	13,633	–	–	﹤0.01%	2964
2015 Q2	$305K	Hold	13,633	–	–	﹤0.01%	2876
2015 Q1	$276K	Hold	13,633	–	–	﹤0.01%	2868
2014 Q4	$225K	Hold	13,633	–	–	﹤0.01%	2952
2014 Q3	$208K	Hold	13,633	–	–	﹤0.01%	2939
2014 Q2	$342K	Buy	+13,633	New	+$311K	﹤0.01%	2800

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Charles Schwab's CYTR Position: Q2 2017 in Review

Charles Schwab sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 21,000 shares — an estimated $56K sold.

Charles Schwab first reported a position in CYTR in Q2 2014 and held it in 12 quarters. The position peaked at $342K in Q2 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

Charles Schwab reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
Charles Schwab sold 21,000 CytRx Corp shares in Q2 2017, an estimated $56K.
Charles Schwab first reported a position in CytRx Corp in Q2 2014 and held it in 12 quarters.
Charles Schwab's CytRx Corp position peaked at $342K in Q2 2014.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.